Its domestic business grew by 10.4 per cent while export growth was muted despite orders in hand due to delayed shipments.

The board of directors have recommended the dividend of Rs. 25 per share on equity share of Rs. 2 per share.

Ineos Styrolution reported strong quarterly performance across the board. The specialties business revenue also witnessed traction

Glenmark Pharmaceuticals launches its first inhaled respiratory product in Europe. The company has marketing and distribution right for the product in Europe.

Overall volumes in futures & options currently stand at 1.21 crore contracts with a turnover of Rs. 11,31,488.68 crore.

Overall volumes in futures & options currently stand at 1.21 crore contracts with a turnover of Rs. 11,31,488.68 crore.

A follow-through weakness and a close below the Monday’s session low (10,774) would signal a reversal in the market. In that case, we could see correction up to the levels of 10,690-10,650. Stocks in news: DLF, Shree Pushkar Chemicals and Fertilisers, Syngene International, MCX, Wockhardt, EPC Industries, Reliance Communications, Cyient and Tata Steel.

Indian markets are likely to make a pessimistic start tracking weak global cues. The sentiments may remain dampened as the US treasury yield on the 10-year benchmark surged to its highest level since 2011, which indicates a more hawkish Federal Reserve going ahead with rate hikes and that would not go down well with the emerging markets.

The share price of pharmaceutical major Sun Pharma plunged by over 7 per cent during the previous week on the back of declining sales of its key specialty products and speculation about price erosion.  

Every investor wants his investment to outperform. The mutual fund arena is well-known for steady returns in the longer term. But it too needs some diligence and planning to achieve maximum returns.